Spatial Multiplexed Protein Profiling of Cardiac Ischemia-Reperfusion Injury

Luyan Yao1, Funan He1, Quanyi Zhao1,2

  • 1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (L.Y., F.H., Q.Z., D.L., S.F., M.Z., X.Z., B.Z., L.W.).

PubMed

Insights

Understanding cardiac cell spatial organization is key to minimizing heart attack reperfusion injury. Targeting H3K9me3 in endothelial cells shows promise for reducing cardiac damage and remodeling after myocardial infarction.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Proteomics and Genomics

Background:

  • Reperfusion therapy is vital for salvaging heart muscle after myocardial infarction but can cause ischemia-reperfusion injury (IRI).
  • Limited knowledge of cardiac cell spatial organization impedes the development of interventions to mitigate IRI effects.

Purpose of the Study:

  • To characterize the spatial distribution and dynamics of cardiac cell phenotypes and communities following IRI using imaging mass cytometry.
  • To identify potential therapeutic targets for minimizing IRI-induced cardiac damage.

Main Methods:

  • Utilized imaging mass cytometry on mouse left ventricle sections across 12 cardiac segments and 8 time points.
  • Analyzed 251 multiplexed images, identifying over 197,000 single cells grouped into 23 distinct cell communities.
  • Investigated protein posttranslational modifications, focusing on H3K9me3 in endothelial cells.

Main Results:

  • Revealed heterogeneous and dynamic cardiac cellular architecture following IRI.
  • Identified increased H3K9me3 in endothelial cells as a key regulatory response during the middle stage of IRI.
  • Demonstrated that manipulating H3K9me3 levels (silencing Suv39h1 or overexpressing Kdm4d) attenuated cardiac dysfunction and remodeling post-IRI.

Conclusions:

  • Mapped the spatiotemporal heterogeneity of cardiac cellular phenotypes after IRI.
  • Uncovered H3K9me3 in endothelial cells as a potential therapeutic target to alleviate pathological remodeling in myocardial IRI.
Abstract